This was just an example of a process I expect labs wouldn't commit to, not (necessarily!) a suggestion.
The key criterion isn't even appropriate levels of understanding, but rather appropriate levels of caution - and of sufficient respect for what we don't know. The criterion [...if aysja thinks it's good for global safety] may well be about as good as [...if Eliezer thinks it's good for global safety].
It's much less about [This person knows], than about [This person knows that no-one knows, and has integrated this knowledge into their decision-making].
Importantly, a cautious person telling an incautious person "you really need to be cautious here" is not going to make the incautious person cautious (perhaps slightly more cautious than their baseline - but it won't change the way they think).
A few other thoughts:
COI: I am a research scientist at Anthropic, where I work on model organisms of misalignment; I was also involved in the drafting process for Anthropic’s RSP. Prior to joining Anthropic, I was a Research Fellow at MIRI for three years.
Thanks to Kate Woolverton, Carson Denison, and Nicholas Schiefer for useful feedback on this post.
Recently, there’s been a lot of discussion and advocacy around AI pauses—which, to be clear, I think is great: pause advocacy pushes in the right direction and works to build a good base of public support for x-risk-relevant regulation. Unfortunately, at least in its current form, pause advocacy seems to lack any sort of coherent policy position. Furthermore, what’s especially unfortunate about pause advocacy’s nebulousness—at least in my view—is that there is a very concrete policy proposal out there right now that I think is basically necessary as a first step here, which is the enactment of good Responsible Scaling Policies (RSPs). And RSPs could very much live or die right now based on public support.
If you’re not familiar with the concept of an RSP, the central idea of RSPs is evaluation-gated scaling—that is, AI labs can only scale models depending on some set of evaluations that determine whether additional scaling is appropriate. ARC’s definition is:
How do we make it to a state where AI goes well?
I want to start by taking a step back and laying out a concrete plan for how we get from where we are right now to a policy regime that is sufficient to prevent AI existential risk.
The most important background here is my “When can we trust model evaluations?” post, since knowing the answer to when we can trust evaluations is extremely important for setting up any sort of evaluation-gated scaling. The TL;DR there is that it depends heavily on the type of evaluation:
With that as background, here’s a broad picture of how things could go well via RSPs (note that everything here is just one particular story of success, not necessarily the only story of success we should pursue or a story that I expect to actually happen by default in the real world):
Reasons to like RSPs
Obviously, the above is only one particular story for how things go well, but I think it’s a pretty solid one. Here are some reasons to like it:
How do RSPs relate to pauses and pause advocacy?
In my opinion, RSPs are pauses done right: if you are advocating for a pause, then presumably you have some resumption condition in mind that determines when the pause would end. In that case, just advocate for that condition being baked into RSPs! And if you have no resumption condition—you want a stop rather than a pause—I empathize with that position but I don’t think it’s (yet) realistic. As I discussed above, it requires labs and governments to sacrifice too much present value (rather than just potential future value), isn’t legibly risk-based, doesn’t provide early wins, etc. Furthermore, I think the best way to actually make a full stop happen is still going to look like my story above, just with RSP thresholds that are essentially impossible to meet.
Furthermore, I want to be very clear that I don’t mean “stop pestering governments and focus on labs instead”—we should absolutely try to get governments to adopt RSP-like policies and get as strong conditions as possible into any RSP-like policies that they adopt. What separates pause advocacy from RSP advocacy isn’t who it’s targeted at, but the concreteness of the policy recommendations that it’s advocating for. The point is that advocating for a “pause” is nebulous and non-actionable—“enact an RSP” is concrete and actionable. Advocating for labs and governments to enact as good RSPs as possible is a much more effective way to actually produce concrete change than highly nebulous pause advocacy.
Furthermore, RSP advocacy is going to be really important! I’m very worried that we could fail at any of the steps above, and advocacy could help substantially. In particular: